CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net income		$ 892	$ 835	$ 1,010
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes		(27)	(44)	161
Provision for inventories		43	39	33
Depreciation and amortization		95	90	108
Loss on disposal of property and equipment		0	1	0
Amortization of capitalized software development costs and intellectual property licenses	[1]	399	256	207
Amortization of debt discount and debt financing costs		7	7	1
Stock-based compensation expense	[2]	92	104	108
Excess tax benefits from stock awards		(67)	(39)	(29)
Changes in operating assets and liabilities:
Accounts receivable, net		(40)	(177)	198
Inventories		(54)	(2)	6
Software development and intellectual property licenses		(350)	(349)	(268)
Other assets		21	18	(67)
Deferred revenues		(27)	475	(275)
Accounts payable		(25)	(12)	7
Accrued expenses and other liabilities		233	90	64
Net cash provided by operating activities		1,192	1,292	1,264
Cash flows from investing activities:
Proceeds from maturities of available-for-sale investments		145	21	304
Proceeds from sales of available-for-sale investments		0	0	98
Purchases of available-for-sale investments		(145)	0	(26)
Acquisition of business (see Note 23)		(46)	0	0
Cash in escrow (see Note 24)		(3,561)	0	0
Capital expenditures		(111)	(107)	(74)
Decrease in restricted cash		2	2	6
Net cash (used in) provided by investing activities		(3,716)	(84)	308
Cash flows from financing activities:
Proceeds from issuance of common stock to employees		106	175	158
Tax payment related to net share settlements on restricted stock rights		(83)	(66)	(49)
Excess tax benefits from stock awards		67	39	29
Repurchase of common stock		0	0	(5,830)
Dividends paid		(170)	(147)	(216)
Proceeds from issuance of long-term debt		0	0	4,750
Repayment of long-term debt		(250)	(375)	(6)
Payment of debt financing costs		(7)	0	(59)
Proceeds received from shareholder settlement		202	0	0
Net cash used in financing activities		(135)	(374)	(1,223)
Effect of foreign exchange rate changes on cash and cash equivalents		(366)	(396)	102
Net (decrease) increase in cash and cash equivalents		(3,025)	438	451
Cash and cash equivalents at beginning of period		4,848	4,410	3,959
Cash and cash equivalents at end of period		$ 1,823	$ 4,848	$ 4,410

[1] Excludes deferral and amortization of stock-based compensation expense.

[2] Includes the net effects of capitalization, deferral, and amortization of stock-based compensation expense.